1.Research progress in cancer genomics.
Chinese Journal of Oncology 2006;28(7):555-557
3.New trends in research on cancer genomics.
Chinese Journal of Oncology 2007;29(7):544-544
DNA Methylation
;
DNA, Neoplasm
;
genetics
;
Genomics
;
trends
;
Human Genome Project
;
Humans
;
Neoplasms
;
genetics
;
Research
4.Genetic analysis of complex diseases: status quo and prospects.
Acta Academiae Medicinae Sinicae 2009;31(6):661-663
This review comments the status quo, especially the major problems, of the genetic analysis of the complex diseases, provides some possible solutions, and explores the further development trends in this field.
Genetic Testing
;
Humans
5.Peroxisome proliferator activated receptor gamma Pro12Ala: old topic of conversation and new question.
Acta Academiae Medicinae Sinicae 2011;33(6):591-592
Comments concerning Meta analysis for relationship between peroxisome proliferator activated receptor gamma Pro12Ala polymorphism and type 2 diabetes susceptibility in different cohorts in this mini review were given. The comments pointed out existent problems and presented suggestions for genetic analysis of diseases in Chinese populations.
Asian Continental Ancestry Group
;
genetics
;
Diabetes Mellitus, Type 2
;
genetics
;
Genetic Predisposition to Disease
;
Humans
;
PPAR gamma
;
genetics
;
Polymorphism, Genetic
7.Study on serological cross-reactivity of six pathogenic phleboviruses.
Wei WU ; Shuo ZHANG ; Quan-Fu ZHANG ; Chuan LI ; Mi-Fang LIANG ; De-Xin LI
Chinese Journal of Virology 2014;30(4):387-390
This article aimed to study the antigenicity of nucleocapsid proteins (NPs) in six pathogenic phleboviruses and to provide theoretical evidence for the development of serological diagnostic reagents. NPs of six pathogenic phleboviruses were expressed and purified using a prokaryotic expression system and rabbits were immunized with individual recombinant NPs. Cross-reactions among NPs and rabbit sera were determined by both indirect ELISA and Western blotting analyses, and the sera titer was determined by indirect ELISA. Furthermore, sera from SFTS patients were also detected by each recombinant NP as a coating antigen using indirect ELISA. The cross-reactions and the sera titer were subsequently determined. Both the concentration and purity of recombinant NPs of six pathogenic phleboviruses met the standards for immunization and detection. The results of indirect ELISA and Western blotting showed that each anti-phlebovirus NP rabbit immune serum had potential serological cross-reactivity with the other five virus NP antigens. Furthermore, the sera from SFTS patients also had cross-reactivity with the other five NP antigens to a certain extent. Our preliminary study evaluated the antigenicity and immune reactivity of six pathogenic phleboviruses NPs and laid the foundation for the development of diagnostic reagents.
Animals
;
Antibodies, Viral
;
immunology
;
Antigens, Viral
;
genetics
;
immunology
;
Cross Reactions
;
Humans
;
Nucleocapsid Proteins
;
genetics
;
immunology
;
Phlebotomus Fever
;
diagnosis
;
immunology
;
virology
;
Phlebovirus
;
classification
;
genetics
;
immunology
;
isolation & purification
;
Rabbits
8.Cloning , Expression of Human sTNFR1 Gene and the Biological Activity of Its Recombinant Protein
Lei FU ; Shi-Fang PENG ; De-Ming TAN ; Hong-Bo LIU ;
China Biotechnology 2006;0(07):-
Human sTNFR1 (soluble tumor necrosis factor receptor 1) gene was amplified by RT-PCR from Hela cells. A recombinant expression vector of sTNFR1-MBP was constructed in pMAL-c2x, and transformed into E. Coli JM109.It was sequenced and confirmed to be identifical to the sTNFR1 gene in data bank. Recombinant protein sTNFR1-MBP was induced by IPTG and purified by Amylose resin Affinity Chromatography. sTNFR1-MBP was binded to sTNFR1's antibody in Western-blotting. From MTT assays, the results showed that sTNFR1-MBP could effectively block the cytotoxicity mediated by TNF?on QSG7701 cells. Annexin V-FITC staining and flowcytometry were used to observe the recombinant protein's anti-apoptosis capacity and the recombinant protein has marked anti-apoptosis effect in vitro.sTNFR1-MBP had good biological activity and it will be employed in further study.
9.Fudenine, Relative to Blood Glucose-control, Is a Novel Membrane Protein
Yong-Sheng CHANG ; JIN ZUO ; Xue-Feng ZHANG ; Ming ZHANG ; Fu-De FANG
Acta Academiae Medicinae Sinicae 2001;23(1):63-64
Objective To determine whether Fudenine is a novel membrane protein. Methods Green fluorescence protein(GFP)was used to localize Fudenine in vivo. GFP, as a control, was targeted to cytoplasm.Epithelial cell, CBRH7919, and non-epithelial cell, L-6TG, were cultured and transiently transfected by using the lipofectamine reagent. After 48 h, intact cells were examined with fluorescence microscope for Fudenine. Results Reporter plasmid pEGFP-N1, as a control , was expressed and localized to cytoplasm. But Fudenine, driven by the cytomegalovirus promoterenhancer contained in the pEGFP-N1 vector, was overexpressed and targeted to cellular membrane. Conclusions Fudenine is a novel membrane protein. It may play the similar role with its homologues AC133 antigen and prominin in human and mouse.respectively. It might be involved in signaling transduction and regulate blood glucose metabolism in vivo.